Related Stories

GSK’s Nucala secures NICE COPD endorsement

pharminent May 29, 2026

Medicare Advantage Out-of-Pocket Limits: Variation and Trends

pharminent May 28, 2026

France ‘first EU country to cover obesity drugs’

pharminent May 28, 2026

You May Have Missed

Lilly and Novo face off at ADA 2026 as others seek to compete in obesity

pharminent June 5, 2026

Medicare Advantage in 2026: Enrollment Update and Key Trends

pharminent June 5, 2026

The next FDA commissioner must be a champion for gene therapies

pharminent June 5, 2026

Otsuka energizes IgA neuropathy space with new Phase 3 Voyxact data

pharminent June 5, 2026